Pasar al contenido principal

CARACTERIZACION Y MODULACION DE LAS CELULAS T DE MEMORIA RESIDENTES CD8+ PARA EL CONTROL Y ELIMINACION DE LOS RESERVORIOS VIRALES

PI20/00160

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Intraepithelial CD15 infiltration identifies high-grade anal dysplasia in people with HIV

  • Burgos, Joaquín|||0000-0001-8445-3047
  • Benítez-Martínez, Aleix
  • Mancebo, Cristina
  • Massana, Núria|||0000-0002-5403-3161
  • Astorga-Gamaza, Antonio|||0000-0002-1276-5276
  • Castellvi, Josep|||0000-0001-5745-9996
  • Landolfi, Stefania|||0000-0002-1059-635X
  • Curran, Adrian|||0000-0002-1263-0814
  • García Pérez, Jorge Néstor|||0000-0003-4986-6094
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Buzón, Maria José|||0000-0003-4427-9413
  • Genescà Ferrer, Meritxell|||0000-0001-6413-3812
Men who have sex with men (MSM) with HIV are at high risk for squamous intraepithelial lesion (SIL) and anal cancer. Identifying local immunological mechanisms involved in the development of anal dysplasia could aid treatment and diagnostics. Here, we studied 111 anal biopsies obtained from 101 MSM with HIV, who participated in an anal screening program. We first assessed multiple immune subsets by flow cytometry, in addition to histological examination, in a discovery cohort. Selected molecules were further evaluated by immunohistochemistry in a validation cohort. Pathological samples were characterized by the presence of resident memory T cells with low expression of CD103 and by changes in natural killer cell subsets, affecting residency and activation. Furthermore, potentially immunosuppressive subsets, including CD15 + CD16 + mature neutrophils, gradually increased as the anal lesion progressed. Immunohistochemistry verified the association between the presence of CD15 in the epithelium and SIL diagnosis for the correlation with high-grade SIL. A complex immunological environment with imbalanced proportions of resident effectors and immune-suppressive subsets characterized pathological samples. Neutrophil infiltration, determined by CD15 staining, may represent a valuable pathological marker associated with the grade of dysplasia. Assessment of changes in relevant anal dysplasia-associated mucosal immune subsets provides potential targets for immunotherapy and a complementary biomarker for current diagnostics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption

  • Sánchez Gaona, Nerea|||0000-0003-1977-8691
  • Perea, David|||0000-0003-1562-4740
  • Curran, Adrian|||0000-0002-1263-0814
  • Burgos, J.
  • Navarro, Jordi|||0000-0002-7187-0367
  • Suanzes, Paula|||0000-0002-6871-0098
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Martín Gayo, Enrique|||0000-0002-2619-6086
  • Genescà Ferrer, Meritxell|||0000-0001-6413-3812
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Buzón, Maria José|||0000-0003-4427-9413
HIV infection remains incurable as the virus persists within a latent reservoir of CD4 + T cells. Novel approaches to enhance immune responses against HIV are essential for effective control and potential cure of the infection. In this study, we designed a novel tetravalent bispecific antibody (Bi-Ab32/16) to simultaneously target the gp120 viral protein on infected cells, and the CD16a receptor on NK cells. In vitro, Bi-Ab32/16 triggered a potent, specific, and polyfunctional NK-dependent response against HIV-infected cells. Moreover, addition of the Bi-Ab32/16 significantly reduced the latent HIV reservoir after viral reactivation and mediated the clearance of cells harboring intact proviruses in samples from people with HIV (PWH). However, the in vivo preclinical evaluation of Bi-Ab32/16 in humanized mice expressing IL-15 (NSG-Hu-IL-15) revealed a significant decline of NK cells associated with poor virological control after ART interruption. Our study underscores the need to carefully evaluating strategies for sustained NK cell stimulation during ART withdrawal. Bispecific antibody targeting NK cells facilitates clearance of HIV-infected cells in vitro but poses challenges in sustaining NK cell function during ART withdrawal in preclinical models.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency

  • Gallego-Cortés, A
  • Sánchez-Gaona, N
  • Mancebo-Pérez, C.
  • Ruiz-Isant, O
  • Benítez-Martínez, A
  • Landolfi, S
  • Castellví, J
  • Pumarola, F
  • Ortiz, N
  • Llano, I
  • Lorente, J
  • Mañalich-Barrachina, L
  • Prado, J G
  • Martín-Gayo, E
  • Falcó, V
  • Genescà, M
  • Buzon, M J
HIV persists in diverse tissues, with distinct cellular reservoirs presenting a major barrier to a cure and requiring targeted therapeutic strategies to address this heterogeneity. Here, we develop tissue models of HIV latency using human tonsillar, intestinal and cervicovaginal tissues. These models reveal differential HIV infection across CD4 T-cell subpopulations, with ART partially restoring CD4 T cells and reducing intact HIV DNA. T follicular helper cells (T) are the primary inducible reservoir in tonsils, while tissue-resident memory cells (T) dominate in the intestine. Identification of markers for inducible reservoirs shows that CD69, CD45RO, and PD-1 are shared across tissues, while CXCR5 in tonsils and CD49a in the intestine act as tissue-specific markers. Furthermore, using different latency reversal agents (LRAs) demonstrates that Histone Deacetylase Inhibitors (HDACis) fail to induce HIV in any tissue, the SMAC mimetic AZD5582 is effective only in a resident-memory CD4 T-cell subpopulation in the intestine, and IL-15 exhibits the broadest reactivation potential across tissues and CD4 T-cell subsets. These models provide insights into the inducible reservoir’s composition in different tissues and inform strategies for its elimination., This study was funded by “la Caixa” Foundation (ID 100010434) under the project code LCF/PR/HR20/00218. This study also received funding from the Agencia Estatal de Investigación project PID2021-123321OB-I00 and PID2024-155881OB-100 supported by MCIN/AEI/10.13039/501100011033/FEDER, UE; The Spanish “Ministerio de Economía y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160); and the Gilead fellowships GLD21-00049, GLD22/00152 and GLD24/00014. MJB is supported by the Miguel Servet programme of the Spanish Health Institute Carlos III (CP17/00179 and CPII22/00005), and AGC is a recipient of a PhD fellowship from “la Caixa” Foundation (LCF/BQ/DI20/11780014). The funders had no role in the design of the study, data collection or analysis, decision to publish, or manuscript preparation.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A lipid hydrogel to transport and release an anti-HIV-1 peptide into vaginal mucosa

  • Loza i Rodríguez, Noèlia
  • Millán Sánchez, Aina
  • Pons, Ramon
  • Gómara, María José
  • Haro, Isabel
  • Benítez Martínez, Aleix
  • Genescà Ferrer, Meritxell
Lipid hydrogel; Peptide; Vaginal mucosa, Hidrogel lipídico; Péptido; Mucosa vaginal, Hidrogel lipídic; Pèptid; Mucosa vaginal, The cervicovaginal mucosa is a main portal of entry for the human immunodeficiency virus (HIV). Peptide antiretroviral therapy is a promising treatment to decrease the HIV infection rate, but yet it presents several weaknesses such as poor bioavailability, development of drug resistance and poor ability to reach the mucosal tissue with the effective concentration. In this work, an HIV inhibitor peptide (RE-E1P47) was encapsulated into a lipidic hydrogel (HG) to test its capacity to deliver the peptide to mucosa ex vivo and its pre-exposure prophylactic efficacy to inhibit or limit HIV infection. The proposed HG is made only with lipids and water and has a composition similar to the vaginal fluid that naturally covers the mucosa. Characterization studies with confocal microscopy, ATR-FTIR, SAXS and WAXS reveal that peptide incorporation does not alter the hydrogel's micro- and nanostructure. Permeation and diffusion tests confirm peptide delivery to the surface layers of the mucosal tissue without interaction or diffusion into a vaginal fluid simulant (VFS). Importantly, efficacy studies demonstrate a significant reduction in HIV infection rates of 60% after HG treatment. Thus, we highlight this material formulation as a strong candidate for mucosal topical application, particularly in the development of pre-exposure prophylaxis (PrEP) treatments against HIV-1., This work was supported by funds from the Spanish Ministry of Science and Innovation with Ayudas para contratos para la formación de doctores en empresas “Doctorados Industriales”, DIN2019-010777, Bicosome S. L., the Mechanism for the Recovery and Resilience of the European Union and MICINN with the CPP2021-008954 project and PID2021-124848OB-I00 project. This work was also supported by grants from the Spanish Health Institute Carlos III (ISCIII, PI20/00160), cofunded by ERDF/ESF, “A way to make Europe”/“Investing in your future”, from MCIN/AEI/10.13039/501100011033 and the European Union “Next Generation EU”/PRTR (CNS2022-135549 and PID2023-149204OB-I00), the Fundació La Marató TV3 (201814-10 FMTV3) and Gilead fellowships (GLD21/00049 and GLD23/00012) to M. G. M. J. G. and I. H. acknowledge the Grant PID2021-122216-OB-I00 received from the Spanish Ministry of Science, Innovation and Universities and the European Regional Development Fund.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants

  • González Robles, Alba
  • Gallego-Cortés, Ana
  • Ortiz Laredo, Nuria
  • Llano, Ines
  • Perea Pérez, David
  • Sánchez Gaona, PhD, Nerea
  • Pumarola, Felix
  • Lorente, Juan
  • Falcó, Vicenç
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
HIV infection; NK cells, Infección por VIH; Células NK, Infecció per VIH; Cèl·lules NK, Natural killer (NK) cells are pivotal effectors in antiviral immunity, yet their tissue-specific roles during acute HIV infection remain poorly defined. Using an ex vivo human tonsillar tissue model, we profile NK cell responses to early HIV infection and uncover distinct subsets with specialized functions. We identify a previously uncharacterized memory-like NK population (CD16+/−CD69+CD49a+CD103+NKG2C+) associated with reduced viral burden and enriched in cytotoxic mediators (GNLY, PRF1, and GZMB), apoptotic ligands (FASLG and TRAIL), cytokine receptors (IL2RA, IL2RB, IL2RG, IL12RB2, and IL18R1) and trafficking molecules (CCL3–5, CCR7, and SELL). Although functionally capable of clearing HIV-infected CD4+ T cells in a tissue-mimetic environment, they show impaired cytotoxicity and transcriptional signs of exhaustion after infection. Conversely, HIV drives the reprogramming of immature CD16−CD69+ NK cells toward a more cytotoxic and migratory effector phenotype. These findings reveal dynamic NK cell adaptations in lymphoid tissue during early HIV infection and highlight tissue-resident NK cells as promising targets for immunotherapeutic intervention., The project leading to these results has received funding from “la Caixa” Banking Foundation under the project code [LCF/PR/HR20-00218] to M.J.B. This study was supported by the Agencia Estatal de Investigación project PID2021-123321OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE to M.J.B.; the Spanish “Ministerio de Economía y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160) to M.G.; and the Gilead fellowship GLD22/00152 to M.J.B. M.J.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CPII22/00005). D.P. was supported by the VHIR 2020 Ph.D. Fellowship. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Targeting HIV persistence in the tissue

  • Pieren, Daan
  • Benítez Martínez, Aleix
  • Genescà Ferrer, Meritxell
HIV; Tissue, VIH; Tejido, VIH; Teixit, Purpose of review The complex nature and distribution of the HIV reservoir in tissue of people with HIV remains one of the major obstacles to achieve the elimination of HIV persistence. Challenges include the tissue-specific states of latency and viral persistence, which translates into high levels of reservoir heterogeneity. Moreover, the best strategies to reach and eliminate these reservoirs may differ based on the intrinsic characteristics of the cellular and anatomical reservoir to reach. Recent findings While major focus has been undertaken for lymphoid tissues and follicular T helper cells, evidence of viral persistence in HIV and non-HIV antigen-specific CD4+ T cells and macrophages resident in multiple tissues providing long-term protection presents new challenges in the quest for an HIV cure. Considering the microenvironments where these cellular reservoirs persist opens new venues for the delivery of drugs and immunotherapies to target these niches. New tools, such as single-cell RNA sequencing, CRISPR screenings, mRNA technology or tissue organoids are quickly developing and providing detailed information about the complex nature of the tissue reservoirs. Summary Targeting persistence in tissue reservoirs represents a complex but essential step towards achieving HIV cure. Combinatorial strategies, particularly during the early phases of infection to impact initial reservoirs, capable of reaching and reactivating multiple long-lived reservoirs in the body may lead the path., This work was primarily supported by grants from the Spanish Health Institute Carlos III (PI20/00160), co-funded by ERDF/ESF, “A way to make Europe”/“Investing in your future”, the Fundació La Marató TV3 (202112–30 FMTV3) and the Gilead fellowships GLD21/00049.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency

  • Gallego-Cortés, Ana
  • Sánchez Gaona, PhD, Nerea
  • Ruiz Isant, Oriol
  • Pumarola, Felix
  • Ortiz Laredo, Nuria
  • Llano Espinosa, Ines
  • Mañalich-Barrachina, Laura
  • Mancebo Pérez, Cristina
  • Benítez Martínez, Aleix
  • Landolfi, Stefania
  • Castellvi, Josep
  • Lorente, Juan
  • Falcó, Vicenç
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
HIV; Tissue models; Cellular reservoirs, VIH; Modelos de tejido; Reservorios celulares, VIH; Models de teixit; Reservoris cel·lulars, HIV persists in diverse tissues, with distinct cellular reservoirs presenting a major barrier to a cure and requiring targeted therapeutic strategies to address this heterogeneity. Here, we develop tissue models of HIV latency using human tonsillar, intestinal and cervicovaginal tissues. These models reveal differential HIV infection across CD4+ T-cell subpopulations, with ART partially restoring CD4+ T cells and reducing intact HIV DNA. T follicular helper cells (TFH CD69+ CCR7-) are the primary inducible reservoir in tonsils, while tissue-resident memory cells (TRM CD69+ CD49a+) dominate in the intestine. Identification of markers for inducible reservoirs shows that CD69, CD45RO, and PD-1 are shared across tissues, while CXCR5 in tonsils and CD49a in the intestine act as tissue-specific markers. Furthermore, using different latency reversal agents (LRAs) demonstrates that Histone Deacetylase Inhibitors (HDACis) fail to induce HIV in any tissue, the SMAC mimetic AZD5582 is effective only in a resident-memory CD4+ T-cell subpopulation in the intestine, and IL-15 exhibits the broadest reactivation potential across tissues and CD4+ T-cell subsets. These models provide insights into the inducible reservoir's composition in different tissues and inform strategies for its elimination., This study was funded by “la Caixa” Foundation (ID 100010434) under the project code LCF/PR/HR20/00218. This study also received funding from the Agencia Estatal de Investigación project PID2021-123321OB-I00 and PID2024-155881OB-100 supported by MCIN/AEI/10.13039/501100011033/FEDER, UE; The Spanish “Ministerio de Economía y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160); and the Gilead fellowships GLD21-00049, GLD22/00152 and GLD24/00014. MJB is supported by the Miguel Servet programme of the Spanish Health Institute Carlos III (CP17/00179 and CPII22/00005), and AGC is a recipient of a PhD fellowship from “la Caixa” Foundation (LCF/BQ/DI20/11780014). The funders had no role in the design of the study, data collection or analysis, decision to publish, or manuscript preparation. We acknowledge María Lázaro and Ruth Peña (JGP research group) for their technical assistance in the production of the HIVBAL viral stock.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir

  • Astorga Gamaza, Antonio
  • Sánchez Gaona, Nerea
  • Calvet-Mirabent, Marta
  • Gallego-Cortés, Ana
  • Rey Cano, Joan
  • Curran, Adrian
  • Grau Exposito, Judith
  • Castellvi, Josep
  • Burgos, Joaquin
  • Navarro, Jordi
  • Suanzes, Paula
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
  • Falcó, Vicenç
  • Perea Pérez, David
HIV infection; HIV reservoir; Immunotherapy, Infección por VIH; Reservorio de VIH; Inmunoterapia, Infecció per VIH; Reservori de VIH; Immunoteràpia, Human immunodeficiency virus (HIV) infection induces immunological dysfunction, which limits the elimination of HIV-infected cells during treated infection. Identifying and targeting dysfunctional immune cells might help accelerate the purging of the persistent viral reservoir. Here, we show that chronic HIV infection increases natural killer (NK) cell populations expressing the negative immune regulator KLRG1, both in peripheral blood and lymph nodes. Antiretroviral treatment (ART) does not reestablish these functionally impaired NK populations, and the expression of KLRG1 correlates with active HIV transcription. Targeting KLRG1 with specific antibodies significantly restores the capacity of NK cells to kill HIV-infected cells, reactivates latent HIV present in CD4+ T cells co-expressing KLRG1, and reduces the intact HIV genomes in samples from ART-treated individuals. Our data support the potential use of immunotherapy against the KLRG1 receptor to impact the viral reservoir during HIV persistence., The project leading to these results has received funding from “la Caixa” Banking Foundation under the project code LCF/PR/HR20-00218. This study was also supported by the Agencia Estatal de Investigación project PID2021-123321OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE; The Spanish “Ministerio de Economia y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160); and the Gilead fellowships GLD19/00084, GLD18/00008, GLD21-00049, and GLD22/00152. Part of the methodology was developed with the support of the grant 202104-30-31 from Fundació la Marató de TV3. M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CPII22/00005). A.A.-G. was supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (BES-2016-076382). D.P. was supported by the VHIR Ph.D programme 2020. Spanish Secretariat of Science and Innovation Ph.D. fellowship. E.M.G. was supported by the Ramón y Cajal Program (RYC2018-024374-I) funded by the Spanish Secretariat of Science and Innovation, by the Comunidad de Madrid Talento Program (2017-T1/BMD-5396), and by the project PID2021-127899OB-I00 funded by MCIN /AEI /10.13039/501100011033/ FEDER, UE. We thank Dr. Joan Puñet from the flow cytometry core at the Vall d’Hebron Research Institute for his technical and scientific expertise. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Intraepithelial CD15 infiltration identifies high-grade anal dysplasia in people with HIV

  • Mancebo Pérez, Cristina
  • Massana, Nuria
  • Astorga Gamaza, Antonio
  • Burgos, Joaquin
  • Benítez Martínez, Aleix
  • Castellvi, Josep
  • Landolfi, Stefania
  • Curran, Adrian
  • García Pérez, Jorge N.
  • Buzon, Maria Jose
  • Genescà Ferrer, Meritxell
  • Falcó, Vicenç
Adaptive immunity; Immunology; Infectious disease, Immunitat adaptativa; Immunologia; Malaltia infecciosa, Inmunidad adaptativa; Inmunología; Enfermedad infecciosa, Men who have sex with men (MSM) with HIV are at high risk for squamous intraepithelial lesion (SIL) and anal cancer. Identifying local immunological mechanisms involved in the development of anal dysplasia could aid treatment and diagnostics. Here, we studied 111 anal biopsies obtained from 101 MSM with HIV, who participated in an anal screening program. We first assessed multiple immune subsets by flow cytometry, in addition to histological examination, in a discovery cohort. Selected molecules were further evaluated by immunohistochemistry in a validation cohort. Pathological samples were characterized by the presence of resident memory T cells with low expression of CD103 and by changes in natural killer cell subsets, affecting residency and activation. Furthermore, potentially immunosuppressive subsets, including CD15+CD16+ mature neutrophils, gradually increased as the anal lesion progressed. Immunohistochemistry verified the association between the presence of CD15 in the epithelium and SIL diagnosis for the correlation with high-grade SIL. A complex immunological environment with imbalanced proportions of resident effectors and immune-suppressive subsets characterized pathological samples. Neutrophil infiltration, determined by CD15 staining, may represent a valuable pathological marker associated with the grade of dysplasia., The authors thank the study participants. We would also like to thank Cristina de Dios Conde and Marta Valeri Sala from the Microscopy platform at the High Technology Unit (UAT, VHIR) for excellent technical assistance. This work was primarily supported by grants from the Spanish Health Institute Carlos III (ISCIII, PI16/00736 and PI20/00160) and cofunded by ERDF/ESF, “A way to make Europe”/“Investing in your future.” This work was additionally supported in part by the Spanish AIDS network Red Temática Cooperativa de Investigación en SIDA (RD16/0025/0007), the Fundació La Marató TV3 (201814-10FMTV3), and the Gilead fellowships GLD18/00008. MJB is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179). NM was supported by a PhD fellowship from the VHIR. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Intraepithelial CD15 infiltration identifies high-grade anal dysplasia in people with HIV

  • Mancebo Pérez, Cristina
  • Massana, Nuria
  • Astorga Gamaza, Antonio
  • Burgos, Joaquin
  • Benítez Martínez, Aleix
  • Castellvi, Josep
  • Landolfi, Stefania
  • Curran, Adrian
  • García Pérez, Jorge N.
  • Buzon, Maria Jose
  • Genescà Ferrer, Meritxell
  • Falcó, Vicenç
Adaptive immunity; Immunology; Infectious disease, Immunitat adaptativa; Immunologia; Malaltia infecciosa, Inmunidad adaptativa; Inmunología; Enfermedad infecciosa, Men who have sex with men (MSM) with HIV are at high risk for squamous intraepithelial lesion (SIL) and anal cancer. Identifying local immunological mechanisms involved in the development of anal dysplasia could aid treatment and diagnostics. Here, we studied 111 anal biopsies obtained from 101 MSM with HIV, who participated in an anal screening program. We first assessed multiple immune subsets by flow cytometry, in addition to histological examination, in a discovery cohort. Selected molecules were further evaluated by immunohistochemistry in a validation cohort. Pathological samples were characterized by the presence of resident memory T cells with low expression of CD103 and by changes in natural killer cell subsets, affecting residency and activation. Furthermore, potentially immunosuppressive subsets, including CD15+CD16+ mature neutrophils, gradually increased as the anal lesion progressed. Immunohistochemistry verified the association between the presence of CD15 in the epithelium and SIL diagnosis for the correlation with high-grade SIL. A complex immunological environment with imbalanced proportions of resident effectors and immune-suppressive subsets characterized pathological samples. Neutrophil infiltration, determined by CD15 staining, may represent a valuable pathological marker associated with the grade of dysplasia., The authors thank the study participants. We would also like to thank Cristina de Dios Conde and Marta Valeri Sala from the Microscopy platform at the High Technology Unit (UAT, VHIR) for excellent technical assistance. This work was primarily supported by grants from the Spanish Health Institute Carlos III (ISCIII, PI16/00736 and PI20/00160) and cofunded by ERDF/ESF, “A way to make Europe”/“Investing in your future.” This work was additionally supported in part by the Spanish AIDS network Red Temática Cooperativa de Investigación en SIDA (RD16/0025/0007), the Fundació La Marató TV3 (201814-10FMTV3), and the Gilead fellowships GLD18/00008. MJB is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179). NM was supported by a PhD fellowship from the VHIR. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency

  • Gallego-Cortés, Ana
  • Sánchez Gaona, PhD, Nerea
  • Ruiz Isant, Oriol
  • Pumarola, Felix
  • Ortiz Laredo, Nuria
  • Llano Espinosa, Ines
  • Mañalich-Barrachina, Laura
  • Mancebo Pérez, Cristina
  • Benítez Martínez, Aleix
  • Landolfi, Stefania
  • Castellvi, Josep
  • Lorente, Juan
  • Falcó, Vicenç
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
HIV; Tissue models; Cellular reservoirs, VIH; Modelos de tejido; Reservorios celulares, VIH; Models de teixit; Reservoris cel·lulars, HIV persists in diverse tissues, with distinct cellular reservoirs presenting a major barrier to a cure and requiring targeted therapeutic strategies to address this heterogeneity. Here, we develop tissue models of HIV latency using human tonsillar, intestinal and cervicovaginal tissues. These models reveal differential HIV infection across CD4+ T-cell subpopulations, with ART partially restoring CD4+ T cells and reducing intact HIV DNA. T follicular helper cells (TFH CD69+ CCR7-) are the primary inducible reservoir in tonsils, while tissue-resident memory cells (TRM CD69+ CD49a+) dominate in the intestine. Identification of markers for inducible reservoirs shows that CD69, CD45RO, and PD-1 are shared across tissues, while CXCR5 in tonsils and CD49a in the intestine act as tissue-specific markers. Furthermore, using different latency reversal agents (LRAs) demonstrates that Histone Deacetylase Inhibitors (HDACis) fail to induce HIV in any tissue, the SMAC mimetic AZD5582 is effective only in a resident-memory CD4+ T-cell subpopulation in the intestine, and IL-15 exhibits the broadest reactivation potential across tissues and CD4+ T-cell subsets. These models provide insights into the inducible reservoir's composition in different tissues and inform strategies for its elimination., This study was funded by “la Caixa” Foundation (ID 100010434) under the project code LCF/PR/HR20/00218. This study also received funding from the Agencia Estatal de Investigación project PID2021-123321OB-I00 and PID2024-155881OB-100 supported by MCIN/AEI/10.13039/501100011033/FEDER, UE; The Spanish “Ministerio de Economía y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160); and the Gilead fellowships GLD21-00049, GLD22/00152 and GLD24/00014. MJB is supported by the Miguel Servet programme of the Spanish Health Institute Carlos III (CP17/00179 and CPII22/00005), and AGC is a recipient of a PhD fellowship from “la Caixa” Foundation (LCF/BQ/DI20/11780014). The funders had no role in the design of the study, data collection or analysis, decision to publish, or manuscript preparation. We acknowledge María Lázaro and Ruth Peña (JGP research group) for their technical assistance in the production of the HIVBAL viral stock.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Targeting HIV persistence in the tissue

  • Pieren, Daan
  • Benítez Martínez, Aleix
  • Genescà Ferrer, Meritxell
HIV; Tissue, VIH; Tejido, VIH; Teixit, Purpose of review The complex nature and distribution of the HIV reservoir in tissue of people with HIV remains one of the major obstacles to achieve the elimination of HIV persistence. Challenges include the tissue-specific states of latency and viral persistence, which translates into high levels of reservoir heterogeneity. Moreover, the best strategies to reach and eliminate these reservoirs may differ based on the intrinsic characteristics of the cellular and anatomical reservoir to reach. Recent findings While major focus has been undertaken for lymphoid tissues and follicular T helper cells, evidence of viral persistence in HIV and non-HIV antigen-specific CD4+ T cells and macrophages resident in multiple tissues providing long-term protection presents new challenges in the quest for an HIV cure. Considering the microenvironments where these cellular reservoirs persist opens new venues for the delivery of drugs and immunotherapies to target these niches. New tools, such as single-cell RNA sequencing, CRISPR screenings, mRNA technology or tissue organoids are quickly developing and providing detailed information about the complex nature of the tissue reservoirs. Summary Targeting persistence in tissue reservoirs represents a complex but essential step towards achieving HIV cure. Combinatorial strategies, particularly during the early phases of infection to impact initial reservoirs, capable of reaching and reactivating multiple long-lived reservoirs in the body may lead the path., This work was primarily supported by grants from the Spanish Health Institute Carlos III (PI20/00160), co-funded by ERDF/ESF, “A way to make Europe”/“Investing in your future”, the Fundació La Marató TV3 (202112–30 FMTV3) and the Gilead fellowships GLD21/00049.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir

  • Astorga Gamaza, Antonio
  • Sánchez Gaona, Nerea
  • Calvet-Mirabent, Marta
  • Gallego-Cortés, Ana
  • Rey Cano, Joan
  • Curran, Adrian
  • Grau Exposito, Judith
  • Castellvi, Josep
  • Burgos, Joaquin
  • Navarro, Jordi
  • Suanzes, Paula
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
  • Falcó, Vicenç
  • Perea Pérez, David
HIV infection; HIV reservoir; Immunotherapy, Infección por VIH; Reservorio de VIH; Inmunoterapia, Infecció per VIH; Reservori de VIH; Immunoteràpia, Human immunodeficiency virus (HIV) infection induces immunological dysfunction, which limits the elimination of HIV-infected cells during treated infection. Identifying and targeting dysfunctional immune cells might help accelerate the purging of the persistent viral reservoir. Here, we show that chronic HIV infection increases natural killer (NK) cell populations expressing the negative immune regulator KLRG1, both in peripheral blood and lymph nodes. Antiretroviral treatment (ART) does not reestablish these functionally impaired NK populations, and the expression of KLRG1 correlates with active HIV transcription. Targeting KLRG1 with specific antibodies significantly restores the capacity of NK cells to kill HIV-infected cells, reactivates latent HIV present in CD4+ T cells co-expressing KLRG1, and reduces the intact HIV genomes in samples from ART-treated individuals. Our data support the potential use of immunotherapy against the KLRG1 receptor to impact the viral reservoir during HIV persistence., The project leading to these results has received funding from “la Caixa” Banking Foundation under the project code LCF/PR/HR20-00218. This study was also supported by the Agencia Estatal de Investigación project PID2021-123321OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE; The Spanish “Ministerio de Economia y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160); and the Gilead fellowships GLD19/00084, GLD18/00008, GLD21-00049, and GLD22/00152. Part of the methodology was developed with the support of the grant 202104-30-31 from Fundació la Marató de TV3. M.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CPII22/00005). A.A.-G. was supported by the Spanish Secretariat of Science and Innovation Ph.D. fellowship (BES-2016-076382). D.P. was supported by the VHIR Ph.D programme 2020. Spanish Secretariat of Science and Innovation Ph.D. fellowship. E.M.G. was supported by the Ramón y Cajal Program (RYC2018-024374-I) funded by the Spanish Secretariat of Science and Innovation, by the Comunidad de Madrid Talento Program (2017-T1/BMD-5396), and by the project PID2021-127899OB-I00 funded by MCIN /AEI /10.13039/501100011033/ FEDER, UE. We thank Dr. Joan Puñet from the flow cytometry core at the Vall d’Hebron Research Institute for his technical and scientific expertise. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants

  • González Robles, Alba
  • Gallego-Cortés, Ana
  • Ortiz Laredo, Nuria
  • Llano, Ines
  • Perea Pérez, David
  • Sánchez Gaona, PhD, Nerea
  • Pumarola, Felix
  • Lorente, Juan
  • Falcó, Vicenç
  • Genescà Ferrer, Meritxell
  • Buzon, Maria Jose
HIV infection; NK cells, Infección por VIH; Células NK, Infecció per VIH; Cèl·lules NK, Natural killer (NK) cells are pivotal effectors in antiviral immunity, yet their tissue-specific roles during acute HIV infection remain poorly defined. Using an ex vivo human tonsillar tissue model, we profile NK cell responses to early HIV infection and uncover distinct subsets with specialized functions. We identify a previously uncharacterized memory-like NK population (CD16+/−CD69+CD49a+CD103+NKG2C+) associated with reduced viral burden and enriched in cytotoxic mediators (GNLY, PRF1, and GZMB), apoptotic ligands (FASLG and TRAIL), cytokine receptors (IL2RA, IL2RB, IL2RG, IL12RB2, and IL18R1) and trafficking molecules (CCL3–5, CCR7, and SELL). Although functionally capable of clearing HIV-infected CD4+ T cells in a tissue-mimetic environment, they show impaired cytotoxicity and transcriptional signs of exhaustion after infection. Conversely, HIV drives the reprogramming of immature CD16−CD69+ NK cells toward a more cytotoxic and migratory effector phenotype. These findings reveal dynamic NK cell adaptations in lymphoid tissue during early HIV infection and highlight tissue-resident NK cells as promising targets for immunotherapeutic intervention., The project leading to these results has received funding from “la Caixa” Banking Foundation under the project code [LCF/PR/HR20-00218] to M.J.B. This study was supported by the Agencia Estatal de Investigación project PID2021-123321OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE to M.J.B.; the Spanish “Ministerio de Economía y Competitividad, Instituto de Salud Carlos III” (ISCIII, PI20/00160) to M.G.; and the Gilead fellowship GLD22/00152 to M.J.B. M.J.B. is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CPII22/00005). D.P. was supported by the VHIR 2020 Ph.D. Fellowship. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

A lipid hydrogel to transport and release an anti-HIV-1 peptide into vaginal mucosa

  • Loza i Rodríguez, Noèlia
  • Millán Sánchez, Aina
  • Pons, Ramon
  • Gómara, María José
  • Haro, Isabel
  • Benítez Martínez, Aleix
  • Genescà Ferrer, Meritxell
Lipid hydrogel; Peptide; Vaginal mucosa, Hidrogel lipídico; Péptido; Mucosa vaginal, Hidrogel lipídic; Pèptid; Mucosa vaginal, The cervicovaginal mucosa is a main portal of entry for the human immunodeficiency virus (HIV). Peptide antiretroviral therapy is a promising treatment to decrease the HIV infection rate, but yet it presents several weaknesses such as poor bioavailability, development of drug resistance and poor ability to reach the mucosal tissue with the effective concentration. In this work, an HIV inhibitor peptide (RE-E1P47) was encapsulated into a lipidic hydrogel (HG) to test its capacity to deliver the peptide to mucosa ex vivo and its pre-exposure prophylactic efficacy to inhibit or limit HIV infection. The proposed HG is made only with lipids and water and has a composition similar to the vaginal fluid that naturally covers the mucosa. Characterization studies with confocal microscopy, ATR-FTIR, SAXS and WAXS reveal that peptide incorporation does not alter the hydrogel's micro- and nanostructure. Permeation and diffusion tests confirm peptide delivery to the surface layers of the mucosal tissue without interaction or diffusion into a vaginal fluid simulant (VFS). Importantly, efficacy studies demonstrate a significant reduction in HIV infection rates of 60% after HG treatment. Thus, we highlight this material formulation as a strong candidate for mucosal topical application, particularly in the development of pre-exposure prophylaxis (PrEP) treatments against HIV-1., This work was supported by funds from the Spanish Ministry of Science and Innovation with Ayudas para contratos para la formación de doctores en empresas “Doctorados Industriales”, DIN2019-010777, Bicosome S. L., the Mechanism for the Recovery and Resilience of the European Union and MICINN with the CPP2021-008954 project and PID2021-124848OB-I00 project. This work was also supported by grants from the Spanish Health Institute Carlos III (ISCIII, PI20/00160), cofunded by ERDF/ESF, “A way to make Europe”/“Investing in your future”, from MCIN/AEI/10.13039/501100011033 and the European Union “Next Generation EU”/PRTR (CNS2022-135549 and PID2023-149204OB-I00), the Fundació La Marató TV3 (201814-10 FMTV3) and Gilead fellowships (GLD21/00049 and GLD23/00012) to M. G. M. J. G. and I. H. acknowledge the Grant PID2021-122216-OB-I00 received from the Spanish Ministry of Science, Innovation and Universities and the European Regional Development Fund.